Healthcare Distribution Alliance – Patients Move Us.
Share Print
News

News

FEATURED NEWS

Results: 115 Articles found.
  • H.R. 471 Approved by House Energy and Commerce Committee
    February 12, 2015

    HDMA President and CEO John M. Gray issued the following statement following the House Energy and Commerce Committee’s approval of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471). The legislation is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif).

  • HDMA Presents Rx Safety and Healthcare Leadership Award to Four Legislative Champions
    February 5, 2015

    HDMA recognized four members of Congress ― Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.) — with the Association’s Rx Safety and Healthcare Leadership Award (or Rx Award). The award honors public officials for their leadership and commitment to policies that promote the safe and efficient delivery of medicines to pharmacies, healthcare providers and their patients. Awards were announced in conjunction with an Association Hill Day event (with several member companies participating), as well as HDMA’s Public Policy Council meeting in Washington, D.C.

  • HDMA-Supported Legislation Addressing Rx Drug Abuse Passes House Subcommittee
    February 4, 2015

    HDMA President and CEO John M. Gray released a statement following the House Energy and Commerce Subcommittee on Health’s markup of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471), sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.)

  • HDMA and Hamacher Resource Group Report Explores Dialogue Between Indepdendent Pharmacists and Patients, Impact on Front-of-Store Sales
    February 3, 2015

    A new study commissioned by HDMA and conducted by Hamacher Resource Group (HRG), Pharmacist and Patient Conversations at Independent Pharmacy, delves into the dialogue between independent pharmacists and their customers and how those communications impact consumer purchasing decisions. The study is based on electronic and phone surveys of independent pharmacists conducted in 2014 and includes secondary research that supports these most recent findings. The report is the fifth in a series focusing on the opportunities for pharmaceutical distributors and manufacturers to support independent pharmacy.

  • Physician's Offices and Clinics Remain Largest Customer Base for Specialty Rx Distributors
    February 3, 2015

    Physician’s offices and independently owned and operated physician clinics remain the largest customer base for specialty pharmaceutical distributors, at 63 percent of their sales value, according to the 2014 Specialty Pharmaceutical Distribution: Facts, Figures and Trends, published by HDMA’s Center for Healthcare Supply Chain Research. The 2014 edition is sponsored by CuraScript Specialty Distribution, an Express Scripts Company; Genentech, A Member of the Roche Group; AstraZeneca Pharmaceuticals LP; and Pharmacy First.

Website design and development by Americaneagle.com, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | O365